Stacy Lindborg - 20 Apr 2023 Form 4 Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Role
Co-Chief Executive Officer
Signature
/s/ Stacy Lindborg
Issuer symbol
BCLI
Transactions as of
20 Apr 2023
Net transactions value
$0
Form type
4
Filing time
24 Apr 2023, 06:42:36 UTC
Previous filing
21 Mar 2023
Next filing
07 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCLI Common Stock Award $0 +75,000 +125% $0.000000 135,000 20 Apr 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired are shares of restricted stock awarded under the Issuer's 2014 Stock Incentive Plan. The shares were fully vested upon grant.